Zheng Xing Xing Ye Ri Bao·2026-01-09 08:54Market Overview - The chemical pharmaceutical sector increased by 1.77% on January 9, with Frontier Biotech leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Top Gainers in Chemical Pharmaceutical Sector - Frontier Biotech (688221) closed at 28.15, up 19.99% with a trading volume of 305,300 shares and a transaction value of 786 million [1] - Shanghai Yizhong (688091) closed at 60.84, up 17.29% with a trading volume of 119,400 shares and a transaction value of 688 million [1] - Yuekang Pharmaceutical (688658) closed at 31.79, up 17.13% with a trading volume of 200,400 shares and a transaction value of 586 million [1] - Lianhuan Pharmaceutical (600513) closed at 21.11, up 10.01% with a trading volume of 130,530 shares and a transaction value of 620 million [1] - Fuyuan Pharmaceutical (601089) closed at 30.27, up 9.99% with a trading volume of 108,600 shares and a transaction value of 31 million [1] Market Capital Flow - The chemical pharmaceutical sector experienced a net outflow of 574 million from institutional investors, while retail investors saw a net inflow of 557 million [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional selling and retail buying [2] Individual Stock Capital Flow - Lianhuan Pharmaceutical (600513) had a net inflow of 180 million from institutional investors, but a net outflow of 68.68 million from retail investors [3] - Frontier Biotech (688221) saw a net inflow of 111 million from institutional investors, with retail investors experiencing a net outflow of 66.19 million [3] - Huahai Pharmaceutical (600521) had a net inflow of 89.80 million from institutional investors, while retail investors faced a net outflow of 60.06 million [3]